Spatiotemporal Theranostic Nanoprobes Dynamically Monitor Targeted Tumor Therapy
Authors:
- 27 July 2023
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (47)
Abstract
Currently, spatiotemporal theranostic nanoprobes are in great demand, owing to their enhanced target therapy and precise dynamic tracing of in vivo drug fate. Herein, this study highlights the successful development of dynamic theranostic nanoprobes, which are facilely established via self‐assembly between glutathione (GSH)‐responsive dasatinib (DAS) dimers and indocyanine green (ICG). The DAS dimers endow the nanoprobes with aggregation‐induced emission (AIE) characteristic, whose emission wavelength successfully redshifts from 420 to 810 nm compared to DAS‐based nanoprobes, the same as that of ICG, thus improving the total fluorescence intensity. Moreover, the nanoprobes exhibit a dynamic fluorescence intensity conversion that first decreases and then increases at the tumor site via intracellular GSH‐triggered AIE quenching and fluorescence re‐enhancement of ICG, therefore achieving precise tumor diagnosis, prognosis evaluation, and spatiotemporal tracing of drug fate compared to other imaging strategies. Furthermore, the nanoprobes show long‐term circulation stability via suitable particle sizes and zeta potentials, improved tumor accumulation via extracellular protonation and active cellular uptake, efficient drug release via response to the intracellular milieu, and enhanced apoptosis via targeting to intracellular kinase, therefore achieving the significant tumor inhibition. Thus, the spatiotemporal theranostic nanoprobes can dynamically monitor the targeted tumor therapy, greatly advancing their application in clinics.Keywords
Funding Information
- National Natural Science Foundation of China (51803001)
This publication has 53 references indexed in Scilit:
- Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for BioimagingSmall, 2016
- AIE luminogens: emission brightened by aggregationMaterials Today, 2015
- Improved Angiostatic Activity of Dasatinib by Modulation with Hydrophobic ChainsACS Medicinal Chemistry Letters, 2015
- Nanomaterials for Theranostics: Recent Advances and Future ChallengesChemical Reviews, 2014
- Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer TherapyJournal of the American Chemical Society, 2014
- Aggregation‐Induced Emission: The Whole Is More Brilliant than the PartsAdvanced Materials, 2014
- The role of “disaggregation” in optical probe developmentChemical Society Reviews, 2014
- Role of ABL family kinases in cancer: from leukaemia to solid tumoursNature Reviews Cancer, 2013
- Bioprobes Based on AIE FluorogensAccounts of Chemical Research, 2013
- Near‐Infrared Light‐Mediated Nanoplatforms for Cancer Thermo‐Chemotherapy and Optical ImagingAdvanced Materials, 2013